8mo
Discussion Prompt: How have payor criteria shaped your timing of anti‑CGRP MAbs, and patient outcomes?
8mo
Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38931273/
The consumption of cocoa showed protective effects on major cardiometabolic risk markers that have a clinical impact in terms of cardiovascular risk reduction.
Cocoa consumption modestly improves LDL-c, total cholesterol, fasting glucose, and blood pressure in adults, but shows no impact on weight, BMI, waist circumference, triglycerides, HDL-c, or HbA1c.
8mo
Intravenous Lipid Emulsion for Managing Local Anesthetic Toxicity in a Three-Month-Old Patient - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39830580/
Local anesthetic systemic toxicity (LAST) is a well-known life-threatening local anesthetics complication, especially if given in inappropriate doses or routes. Therefore, physicians should be aware of LAST symptoms, such as...
A three-month-old infant developed cardiac symptoms from LAST after a caudal block; early intravenous lipid emulsion treatment effectively reversed symptoms, restoring normal vitals without complications.
9mo
ORION‑3 shows 44 % LDL‑C reduction sustained over 4 yrs with 6‑monthly dosing; pooled ORION‑9/10/11 hint at MACE drop. No safety signal beyond mild injection‑site reactions.
Could siRNA free patients from statin fatigue?
9mo
Serum lipidome reveals lipid metabolic dysregulation in severe fever with thrombocytopenia syndrome - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39396989/
Our study presents the first global serum lipidome profile and reveals the lipid metabolic dysregulation patterns in the early stage of SFTSV infection. These findings provide a new basis for...
https://pubmed.ncbi.nlm.nih.gov/39396989/
SFTS patients exhibit early lipid metabolic dysregulation, marked by altered levels of PS, HexCer, TG, LPC, AcCa, ChE, PC, and PE, offering insights for diagnosis and therapeutic development.